Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1987-12-01
1990-01-09
Griffin, Ronald W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
536 24, 536 26, A61K 3152, C07H 1914
Patent
active
048928658
ABSTRACT:
This invention relates to the use of certain substituted pyrrolo[2,3-d]-pyrimidine nucleosides in the treatment of viral infections, in particular those caused by human immunodeficiency virus type 1, herpes simplex virus type 1 and human cytomegalovirus. These substituted compounds retain antiviral properties present in their parent compounds yet exhibit significantly decreased levels of cytotoxicity.
REFERENCES:
patent: 3817982 (1974-06-01), Verheyden et al.
patent: 3962211 (1976-06-01), Townsend et al.
patent: 4229453 (1980-10-01), Roth et al.
patent: 4596798 (1986-06-01), Shipman, Jr. et al.
Bergstrom, D., et al., "Antiviral Activity of C-5 Substituted Tubercidin Analogues", J. Med. Chem., 27:285-292 (1984).
Turk, S. R., et al., "Pyrrolo[2,3-d]Pyrimidine Nucleosides as Inhibitors of Human Cytomegalovirus", Antimicrob. Agents Chemother., 31:544-550 (1987).
DeClercq, E., et al., "Antirhinovirus Activity of Purine Nucleoside Analogs", Antimicrob. Agents Chemother., 29:482-484 (1986).
Shipman, C., Jr., "Antiviral Activity of Arabinosyladenine and Arabinosylhypoxanthine in Herpes Simplex Virus-Infected KB Cells: Selective Inhibition of Viral Deoxyribonucleic Acid Synthesis in Synchronized Suspension Cultures", Antimicrob. Agents Chemother., 9:120-127 (1976).
Mitsuya, H., et al. "3'-Azido-3'deoxythymidine (BW A509U): An Antiviral Agent That Inhibits the Infectivity and Cytopathic Effect of Human T-Lymphtropic Virus Type III/Lymphadenopathy-Associated Virus In Vitro", PNAS (USA), 82:7096-7100 (1985).
Mitsuya, H., et al., "Inhibition of the In Vitro Infectivity and Cytopathic Effect of Human T-Lymphotrophic Virus Type III/Lymphadenopathy-Associated Virus (HTLV-III/LAV) by 2',3'-Dideoxynucleosides", PNAS (USA), 83:1911-1915 (1986).
Smith, C. M., et al., "Inhibitors of Hypoxanthine Metabolism in Ehrlich Ascites Tumor Cells in Vitro", Cancer Treatment Reports, 60:1567-1584 (1976).
Maruyama, T., et al., "Pyrrolopyrimidine Nucleosides. 18. Synthesis and Chemotherapeutic Activity of 4-Amino-7-(3-Deoxy-.beta.-D-Ribofuranosyl)Pyrrolo[2,3-d]Pyrimidine-5-Carbo xamide (3'-Deoxysangivamycin) and 4-Amino-7-(2-Deoxy-.beta.-D-Ribofuranosyl)Pyrrolo[2,3-d]Pyrimidine-5-Carbo xamide (`'-Deoxysangivamycin)", J. Med. Chem., 26:25-29 (1983).
DeClercq, E., et al., "Nucleic Acid Related Compounds. 51. Synthesis and Biological Properties of Sugar-Modified Analogues of the Nucleoside Antibiotics Tubercidin, Toyocamycin, Sangivamycin, and Formycin", J. Med. Chem., 30:481-486 (1987).
Hansske, F., et al., "2' and 3'-Ketonucleosides and Their Arabino and Xylo Reduction Products", Tetrahedron 40:125-135 (1984).
Robins, M. J., et al., "A Mild Conversion of Vicinal Diols to Alkenes, Efficient Transformation of Ribonucleosides into 2'-ene and 2',3'-Dideoxynucleosides", Tetrahedron Letters, 25:367-370 (1984).
Jain, T. C. et al., "Reactions of 2-Acyloxyisobutyryl Halides with Nucleosides. III. Reactions of Tubercidin and Formycin", J. Org. Chem., 38:3179-3186 (1973).
Tolman, R. L., et al., "Pyrrolopyrimidine Nucleosides. III. The Total Synthesis of Toyocamycin, Sangivamycin, Tubercidin, and Related Derivatives", J. Am. Chem. Soc., 91:2102-2108 (1969).
Signas Chemical Co. Catalog, St. Louis, Mo., 1984, p. 898.
Drach John C.
Krawczyk Steven H.
Townsend Leroy B.
Crane L. Eric
Griffin Ronald W.
The Regents of the University of Michigan
LandOfFree
Pyrrolo[2,3-d]pyrimidine nucleosides as antiviral agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrrolo[2,3-d]pyrimidine nucleosides as antiviral agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolo[2,3-d]pyrimidine nucleosides as antiviral agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-145618